Controlled-release formulations of interleukin-2
US5102872A · kind A · utility
93Cited by
7References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1988 |
| Grant date | Apr 7, 1992 |
| Priority date | — |
| Expiry date | Aug 12, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/141
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Shipping fever, and other stress-related diseases in livestock, are treated by administration of a microencapsulated composition comprising IL-2 conjugated with a polyoxyethylene polymer, and mixed with a release-modulating amount of humen serum albumin. The microcapsules are administered parenterally, and release an effective amount of conjugated IL-2 continuously over a period of 14-30 days. These microcapsules are also effective in the treatment of cancer in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.